Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice - Combadière, C; Potteaux, S; Rodero, M (Circulation, 2008)
et al.